바이오인

 

 

 

ABOUT OECD‘S INTERNAL CO-ORDINATION GROUP FOR BIOTECHNOLOGY (ICGB)........... 2
LAUNCH OF PUBLIC CONSULTATIONS FOR GUIDELINES FOR HUMAN BIOBANKS AND GENETIC RESEARCH DATABASES ........................................................................... 2
THE BIOECONOMY TO 2030: DESIGNING A POLICY AGENDA ........................... 3
BIOFUELS .................................................................... 4
HARMONISATION OF REGULATORY OVERSIGHT IN BIOTECHNOLOGY ..................... 4
BIOTRACK ONLINE ......................................................................... 5
SAFETY OF NOVEL FOODS AND FEEDS .................................................. 6
OECD GUIDELINES AND BEST PRACTICES ............................... 7
FORTHCOMING PUBLICATIONS IN BIOTECHNOLOGY AND HEALTH INNOVATION ............... 8
COLLABORATIVE MECHANISMS FOR THE MANAGEMENT OF INTELLECTUAL PROPERTY (IP) ...... 10
BIOMARKERS ................................................... 10
KNOWLEDGE MARKETS IN THE LIFE SCIENCES .......................... 11
OECD INNOVATION STRATEGY: BIOMEDICINE AND HEALTH INNOVATION ................... 12
SYNTHETIC BIOLOGY ........................................... 13
BIOSECURITY ............................................................... 13
BIOLOGICAL RESOURCE CENTRES............................................. 14
INDUSTRIAL BIOTECHNOLOGY .................................................... 15
BIOTECHNOLOGY STATISTICS IN OECD MEMBER COUNTRIES......................................... 15
CO-OPERATIVE RESEARCH PROGRAMME (CRP): BIOLOGICAL RESOURCE MANAGEMENT FOR SUSTAINABLE AGRICULTURAL SYSTEMS.................................................................... 16
OECD'S SEED CERTIFICATION AND FOREST REPRODUCTIVE MATERIAL SCHEMES...................... 19
ECONOMIC INSTRUMENTS FOR BIODIVERSITY ................................................ 20
OECD BIOTECHNOLOGY AND THE WORLD WIDE WEB........................................... 21
FUTURE EVENTS .......................................................... 21
WHO‘S WHO IN BIOTECH AT OECD.................................................... 22
CONTACT POINT:............................................................................ 24
MEDIA ENQUIRIES:............................................................ 24
ENDNOTE: A BRIEF GUIDE TO THE OECD ................................................. 25